Chinese-made new drugs big hit overseas
China DailyEmployees examine drug samples at a laboratory in Shenyang, Liaoning province, in May. With more Chinese-developed innovative drugs entering both US and European markets, China's pharmaceutical sector is showing escalating prowess in innovation and global market penetration, said industry experts. Previously approved by the US FDA in November for treating chemotherapy-induced neutropenia, the approval marks this year's first innovative drug approval for a Chinese pharmaceutical company in a foreign market. "The surge in overseas expansion of domestic innovative drugs highlights the enhanced innovation capabilities of China's biopharmaceutical sector and reflects international regulatory bodies' recognition of China's drug innovation," said Yu Meng, deputy director of the information department at the China Chamber of Commerce for Import and Export of Medicines and Health Products. Specifically, efforts will also include improving scientific and technological resource allocation, strengthening fundamental research in new drug development and solidifying the R&D foundation for China's innovative drugs, according to the guideline.
History of this topic
Big relief for critically ill patients
China Daily
Takeda Eyes China's Second-Largest Market Growth in 5 Years
China DailyBig push for homegrown innovative medicines
China Daily
Big push for homegrown innovative medicines
China Daily
Pharmanovia to boost investment in nation
China Daily
Chinese-made new drugs big hit overseas
China Daily
Drug giants eye China for deals despite growing Sino-US tensions
Hindustan Times
Guideline promotes pharma innovation
China Daily
Guideline promotes pharma innovation
China Daily
Domestic novel drugs R&D makes headway
China Daily
Med-tech of China gaining popularity
China Daily
Indian pharma industry must focus on innovation, say industry leaders
Deccan Chronicle
Foreign pharma firms upbeat on China
China DailyDiscover Related
)
)
